Author:
Vassal G,Pondarré C,Cappelli C,Terrier-Lacombe M.J,Boland I,Morizet J,Bénard J,Vénuat A.M,Ardouin P,Hartmann O,Gouyette A
Reference24 articles.
1. Eukaryotic DNA topoisomerase I: genome gatekeeper and its intruders, camptothecins;Pommier;Semin Oncol,1996
2. Camptothecins: from bench research to hospital wards;Potmesil;Cancer Res,1994
3. Preclinical evaluation of CPT-11 and its active metabolite SN-38;Lavelle;Semin Oncol,1996
4. Irinotecan (CPT-11): current status and perspectives;Boisseau;Exp Opin Invest Drugs,1996
5. Vassal G, Terrier-Lacombe MJ, Bissery MC, et al. Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts. Br J Cancer 1996, 74, 537–545.
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献